6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Breast cancer surveillance following ovarian cancer in BRCA mutation carriers.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          BRCA 1 or 2 mutation carriers have increased risk of developing breast cancer (BC) and serous epithelial ovarian cancer (EOC). The incidence of BC over time after EOC is unknown. Optimal BC surveillance for BRCA mutation carriers following EOC has not been defined.

          Related collections

          Author and article information

          Journal
          Gynecol Oncol
          Gynecologic oncology
          Elsevier BV
          1095-6859
          0090-8258
          Jan 2022
          : 164
          : 1
          Affiliations
          [1 ] Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, CA, USA. Electronic address: catherine.john@unchealth.unc.edu.
          [2 ] Division of Surgical Oncology, Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
          [3 ] Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Oklahoma, Oklahoma City, OK, USA.
          [4 ] Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
          [5 ] Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.
          Article
          S0090-8258(21)01521-3
          10.1016/j.ygyno.2021.10.077
          34862065
          426792da-58cd-49c0-ba06-72b7be2a1452
          History

          Surveillance,BRCA,Breast cancer,Ovarian cancer
          Surveillance, BRCA, Breast cancer, Ovarian cancer

          Comments

          Comment on this article